logo.jpg.jpg
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13 août 2024 08h00 HE | ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
logo.jpg.jpg
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01 août 2024 08h00 HE | ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
logo.jpg.jpg
ViaDerma Provides Highlights of Quarterly Financial Report
06 juin 2024 08h00 HE | ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
logo.jpg.jpg
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
24 oct. 2023 10h30 HE | ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
logo.jpg.jpg
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More 
06 juil. 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
logo.jpg.jpg
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
logo.jpg.jpg
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
08 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company...
logo.jpg.jpg
ViaDerma Provides an Update on Current & Future Business Activities
02 mars 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, March 02, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to provide an update on current business activities. ViaDerma has expanded its licensing agreement with a...
logo.jpg.jpg
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12 janv. 2023 08h00 HE | ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) --  ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
logo.jpg.jpg
ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
15 sept. 2022 05h00 HE | ViaDerma, Inc.
LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the successful completion of its internal quality control testing for their new Vitastem...